UBS Group AG - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q4 2022$7,339
+22.3%
2,033
+174.0%
0.00%
Q3 2022$6,000
-60.0%
742
-61.7%
0.00%
Q2 2022$15,000
-25.0%
1,936
-8.8%
0.00%
Q1 2022$20,000
-48.7%
2,122
-62.1%
0.00%
Q4 2021$39,000
+875.0%
5,594
+1082.7%
0.00%
Q3 2021$4,000
+300.0%
473
+326.1%
0.00%
Q2 2021$1,000
-93.3%
111
-91.7%
0.00%
Q1 2021$15,000
-55.9%
1,337
+41.9%
0.00%
Q4 2020$34,000
+47.8%
942
-41.3%
0.00%
Q3 2020$23,000
+1050.0%
1,604
+1345.0%
0.00%
Q2 2020$2,000
-81.8%
111
-91.3%
0.00%
Q1 2020$11,0001,2760.00%
Other shareholders
LUMOS PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Acuitas Investments, LLC 125,242$413,2990.24%
Lion Point Capital, LP 90,794$299,6200.13%
Greenwich Wealth Management LLC 76,341$2520.03%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 25,760$85,0080.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
Leucadia National 120,651$398,1480.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders